On March 8, 2024, the FDA also approved Wegovy to reduce the risk of serious cardiovascular events in adults with established heart disease and obesity or overweight
In PD, HSP27 protects against -synuclein-induced toxicity by inhibiting its aggregation and reducing oxidative stress, a major contributor to dopaminergic neuronal loss
Peptide therapy requires a valid prescription from a licensed provider
"If you're the branded pharma person, you're the loser in this conversation, but the PBM and particularly the State Health Plan are better off," Briner said
The medication helps control blood sugar by stimulating insulin release, but it also acts on appetite-regulating centres in the brain, slows gastric emptying and reduces overall calorie intake